J&J Plans to Split Into Drug, Consumer Companies

The transcript discusses the strategic decision of companies like Johnson & Johnson and Glaxo to split their businesses, focusing on the lack of synergies between different divisions. It highlights the impact of these decisions on the pharmaceutical industry, including the role of Amazon in distribution and the efficacy of Johnson & Johnson's COVID vaccine. The conversation also touches on shareholder influence and the potential for other companies to follow suit.

Discuss the significance of Amazon's role in the distribution of pharmaceuticals according to the conversation.

What factors might have influenced Johnson & Johnson's decision to split its business segments?